Expand your Gram-negative organism susceptibility testing options by accessing the latest antibiotics including cefiderocol and imipenem/relebactam. The Thermo Scientific™ Sensititre™ MDRGN2F plate delivers results directly from broth microdilution (BMD), the gold standard1 phenotypic method for Antimicrobial Susceptibility Testing (AST). Open access to one of the most comprehensive range of second-line antimicrobials, on a single plate format, designed for in-vitro diagnostic use.
Updated standard format including Cefiderocol and Imipenem/Relebactam
IVD-labelled
BMD provides accurate MIC results guiding treatment optimization
Meets the latest CLSI breakpoints
Sensititre MIC determination is achieved using direct measurement rather than relying on extrapolated data, thereby providing an accurate MIC result, not an estimate.
All contained antibiotics also available in customizable plate options, along with access to over 300 antimicrobials, to enable meeting local formulary and Stewardship program requirements
Thermo Fisher Scientific is a leader in providing AST solutions that help in the fight against antimicrobial resistance, offering high performance automated and manual test options and one of the largest, most up-to-date selections of antimicrobials for susceptibility testing.
The Sensititre System utilizes gold standard-level MIC accuracy1, providing superior quality and reproducibility for accurate results the first time. Broth microdilution is the reference method for AST, and in many cases 2 the most reliable phenotypic method to guide therapeutic decisions.
